Work

Abstract LB-B006: A Phase II chemo/immunotherapy study using metronomic gemcitabine, doxorubicin, docetaxel and nivolumab for advanced angiosarcoma (NCT04535713): An interim analysis

Year: 2026

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2026-lb-b006

Authors: Oliver Davidorf, Sarah Lande, Samantha Jeffrey, Anmol Dia Agarwal, Piya Mann, Allyssa Lingad, Alex Borsada, YuJeong Yoon, Mihir Chawla, Halu Kauffman, Michael Siriprabrydhi, Stephanie Melchor, Neal Chawla, Ania Moradkhani, Ted Kim, Victoria Chua-Alcala, Sant Chawla, Erlinda Gordon

Institution: Sarcoma Oncology Center

Language: English

Topic: Vascular Tumors and Angiosarcomas

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7133646136

Cites:

Cited by:

Related to: